A detailed history of Uss Investment Management LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Uss Investment Management LTD holds 32,871 shares of ALNY stock, worth $8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
32,871
Previous 36,847 10.79%
Holding current value
$8 Million
Previous $8.95 Million 0.99%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$233.81 - $287.01 $929,628 - $1.14 Million
-3,976 Reduced 10.79%
32,871 $9.04 Million
Q2 2024

Aug 13, 2024

BUY
$143.31 - $247.0 $205,363 - $353,951
1,433 Added 4.05%
36,847 $8.95 Million
Q1 2024

May 15, 2024

BUY
$146.51 - $198.2 $543,845 - $735,718
3,712 Added 11.71%
35,414 $5.29 Million
Q4 2023

Feb 14, 2024

SELL
$151.41 - $196.57 $382,915 - $497,125
-2,529 Reduced 7.39%
31,702 $6.07 Million
Q3 2023

Nov 14, 2023

BUY
$170.77 - $211.65 $718,258 - $890,199
4,206 Added 14.01%
34,231 $6.06 Million
Q1 2023

May 12, 2023

SELL
$182.66 - $235.53 $220,835 - $284,755
-1,209 Reduced 3.87%
30,025 $6.01 Million
Q4 2022

Feb 13, 2023

SELL
$185.53 - $241.31 $8.45 Million - $11 Million
-45,569 Reduced 59.33%
31,234 $7.42 Million
Q3 2022

Nov 08, 2022

SELL
$138.54 - $232.0 $50,290 - $84,216
-363 Reduced 0.47%
76,803 $15.4 Million
Q2 2022

Aug 12, 2022

SELL
$120.42 - $169.29 $336,694 - $473,334
-2,796 Reduced 3.5%
77,166 $11.3 Million
Q1 2022

May 13, 2022

BUY
$127.18 - $173.91 $536,953 - $734,248
4,222 Added 5.57%
79,962 $13.1 Million
Q3 2021

Nov 15, 2021

BUY
$169.75 - $207.73 $3.21 Million - $3.92 Million
18,882 Added 33.21%
75,740 $14.3 Million
Q2 2021

Aug 10, 2021

BUY
$128.63 - $176.89 $6.42 Million - $8.83 Million
49,900 Added 717.16%
56,858 $9.64 Million
Q2 2020

Aug 11, 2020

BUY
$104.21 - $156.44 $725,093 - $1.09 Million
6,958 New
6,958 $1.03 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.